Literature DB >> 17307350

Utility of lung density measurements in the diagnosis of emphysema.

Suzanne Marsh1, Sarah Aldington, Mathew V Williams, Michael R Nowitz, Andrew Kingzett-Taylor, Mark Weatherall, Philippa M Shirtcliffe, Amanda A McNaughton, Alison Pritchard, Richard Beasley.   

Abstract

BACKGROUND: The role of computerised tomography (CT) lung density measurements in objective quantification of emphysema is uncertain. The aim of this study was to determine normal reference values for CT lung density measurements and investigate their utility in identifying subjects with clinical emphysema.
METHODS: Normal subjects (non-smokers, no respiratory disease, n=185) and subjects with clinical emphysema (post-bronchodilator FEV(1)/FVC <70%, > or =10 pack years tobacco smoking, no childhood asthma and, either D(LCO)/VA <80% predicted and/or macroscopic emphysema on CT, n=22) were identified from a random population survey. Subjects underwent CT scanning, with measurement of areas of low attenuation as a percentage of total area (RA%) for three standardised slices and two reconstruction algorithms with a density threshold of -950 HU. Reference values in normal subjects, and ability of the measurements to discriminate between the two groups were determined.
RESULTS: Reference values for individual subjects showed wide confidence intervals (standard resolution scans, RA% females 0.2-3.9%, males 0.4-8.7%.) Subjects with emphysema had greater RA% values compared with normal subjects, the difference being most marked in apical slices (standard resolution algorithm, apical slice, median RA% 2.9% (95% CI 0.4-11.1%) vs. 0.1% (95% CI 0.0-0.5%), emphysema vs. normal subjects, respectively). Logistic regression analysis showed poor discriminant ability to distinguish between the groups, the most favourable cut-off yielding a sensitivity and specificity of 83.3% and 62.8%, respectively.
CONCLUSIONS: CT lung density measurements cannot reliably detect the presence of emphysema in an individual. We recommend further investigation into lung density measurements before their widespread use in clinical practice.

Entities:  

Mesh:

Year:  2007        PMID: 17307350     DOI: 10.1016/j.rmed.2007.01.002

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  15 in total

1.  Effects of cannabis on pulmonary structure, function and symptoms.

Authors:  Sarah Aldington; Mathew Williams; Mike Nowitz; Mark Weatherall; Alison Pritchard; Amanda McNaughton; Geoffrey Robinson; Richard Beasley
Journal:  Thorax       Date:  2007-07-31       Impact factor: 9.139

2.  Active relearning for robust supervised training of emphysema patterns.

Authors:  Sushravya Raghunath; Srinivasan Rajagopalan; Ronald A Karwoski; Brian J Bartholmai; Richard A Robb
Journal:  J Digit Imaging       Date:  2014-08       Impact factor: 4.056

3.  Direct assessment of lung function in COPD using CT densitometric measures.

Authors:  Suicheng Gu; Joseph Leader; Bin Zheng; Qihang Chen; Frank Sciurba; Naftali Kminski; David Gur; Jiantao Pu
Journal:  Physiol Meas       Date:  2014-04-08       Impact factor: 2.833

4.  Image reconstruction affects computer tomographic assessment of lung hyperinflation.

Authors:  Andreas W Reske; Harald Busse; Marcelo B P Amato; Matthias Jaekel; Thomas Kahn; Peter Schwarzkopf; Dierk Schreiter; Udo Gottschaldt; Matthias Seiwerts
Journal:  Intensive Care Med       Date:  2008-06-08       Impact factor: 17.440

5.  Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults.

Authors:  Jordan Alexander Zach; John D Newell; Joyce Schroeder; James R Murphy; Douglas Curran-Everett; Eric A Hoffman; Philip M Westgate; MeiLan K Han; Edwin K Silverman; James D Crapo; David A Lynch
Journal:  Invest Radiol       Date:  2012-10       Impact factor: 6.016

6.  Quantifying heterogeneity in emphysema from high-resolution computed tomography: a lung tissue research consortium study.

Authors:  Cuneyt Yilmaz; Dan M Dane; Nova C Patel; Connie C W Hsia
Journal:  Acad Radiol       Date:  2012-10-30       Impact factor: 3.173

7.  Proportional classifications of COPD phenotypes.

Authors:  S E Marsh; J Travers; M Weatherall; M V Williams; S Aldington; P M Shirtcliffe; A L Hansell; M R Nowitz; A A McNaughton; J B Soriano; R W Beasley
Journal:  Thorax       Date:  2008-09       Impact factor: 9.139

8.  Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease.

Authors:  Michael T Borchers; Scott C Wesselkamper; Victor Curull; Alba Ramirez-Sarmiento; Albert Sánchez-Font; Judith Garcia-Aymerich; Carlos Coronell; Josep Lloreta; Alvar G Agusti; Joaquim Gea; John A Howington; Michael F Reed; Sandra L Starnes; Nathaniel L Harris; Mark Vitucci; Bryan L Eppert; Gregory T Motz; Kevin Fogel; Dennis W McGraw; Jay W Tichelaar; Mauricio Orozco-Levi
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

9.  In Vivo Computed Tomography as a Research Tool to Investigate Asthma and COPD: Where Do We Stand?

Authors:  Gaël Dournes; Michel Montaudon; Patrick Berger; François Laurent
Journal:  J Allergy (Cairo)       Date:  2012-01-11

10.  Predicting lung mass density of patients with interstitial lung disease and healthy subjects using deep neural network and lung ultrasound surface wave elastography.

Authors:  Boran Zhou; Brian J Bartholmai; Sanjay Kalra; Xiaoming Zhang
Journal:  J Mech Behav Biomed Mater       Date:  2020-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.